Skip to content
Molecure logo

Molecure Alternatives & Competitors

12 companies similar to Molecure — Fate can be altered.

Companies similar to Molecure

ImmunoMet Therapeutics, Inc. logo — alternative to Molecure

ImmunoMet Therapeutics, Inc.

Targeting Metabolic Reprogramming in Fibrosis and Oncology

Ventus Therapeutics logo — alternative to Molecure

Ventus Therapeutics

Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and...

Angion logo — alternative to Molecure

Angion

Angion is committed to transforming the treatment paradigm for patients suffering from fib...

Ambit logo — alternative to Molecure

Ambit

Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...

Rival Readout

Competing with Molecure? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Treadwell Therapeutics, Inc. logo — alternative to Molecure

Treadwell Therapeutics, Inc.

The Path to Better

Nimbus Therapeutics logo — alternative to Molecure

Nimbus Therapeutics

We develop breakthrough medicines for patients through precision small molecule design.

Promedior logo — alternative to Molecure

Promedior

Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...

Cascadian Therapeutics, Inc. logo — alternative to Molecure
Nexo Therapeutics logo — alternative to Molecure

Nexo Therapeutics

We’re driven to translate the most compelling and still undrugged targets in human biolog...

Pacylex Pharmaceuticals, Inc. logo — alternative to Molecure

Pacylex Pharmaceuticals, Inc.

A new target in cancer care - triggering selective lethality with a new class of drugs.

Evelo Biosciences logo — alternative to Molecure

Evelo Biosciences

Clinical stage biotech company developing a new modality of oral biologics that act on cel...

ORIC Pharmaceuticals Inc. logo — alternative to Molecure

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

About Molecure

Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-class small molecule dr...

Business keywords

Biopharmaceutical, Clinical Stage, Small Molecule Drug Discovery, Immunotherapy, Medicinal Chemistry, Respiratory Diseases, Inflammatory Diseases, Fibrotic Diseases, Chitinase Inhibitor, Arginase Inhibitor, Cancer Treatment, Phase I Clinical Trial, Phase II Clinical Trial, Public Research Partnerships, Listed On Stock Exchange

Frequently Asked Questions

Companies similar to Molecure include ImmunoMet Therapeutics, Inc., Ventus Therapeutics, Angion, Ambit, Treadwell Therapeutics, Inc.. They work in Biotechnology and Health and Wellness and share Molecure's focus on cancer treatment, biopharmaceutical and inflammatory diseases.
Bounce Watch lists 12 companies that share Molecure's industries and are closest to it in business tags, services, target customers, business model and size.
Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-class small molecule dr...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Molecure: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Molecure on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout